Arthur S. Leibowitz - 18 Feb 2026 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
Director
Signature
/s/ William R. Kolb, Attorney-in-Fact
Issuer symbol
ORGO
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
4
Filing time
20 Feb 2026, 17:27:03 UTC
Previous filing
21 Feb 2025
Next filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leibowitz Arthur S Director C/O ORGANOGENESIS HOLDINGS INC., 85 DAN ROAD, CANTON /s/ William R. Kolb, Attorney-in-Fact 20 Feb 2026 0001467329

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGO Class A Common Stock Award $0 +48,828 +21% $0.000000 286,014 18 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027.